Suchergebnisse

Roderer, D.; Bröcker, F.; Sitsel, O.; Kaplonek, P.; Leidreiter, F.; Seeberger, P. H.; Raunser, S.: Glycan-dependent cell adhesion mechanism of Tc toxins. Nature Communications 11, 2694 (2020)

Bröcker, F.; Wegner, E.; Silva Seco, B. M.; Kaplonek, P.; Bräutigam, M.; Ensser, A.; Pfister, F.; Daniel, C.; Martin, C. E.; Mattner, J. et al.; Seeberger, P. H.: Synthetic oligosaccharide-based vaccines protect mice from clostridioides difficile infections. ACS Chemical Biology 14 (12), S. 2720 - 2728 (2019)

Downey, M.; Kaplonek, P.; Seeberger, P. H.: MAIT cells as attractive vaccine targets. FEBS Letters 593, S. 1627 - 1640 (2019)

Kaplonek, P.; Khan, N.; Reppe, K.; Schumann, B.; Emmadi, M.; Lisboa, M. P.; Xu, F.-F.; Calow, A. D. J.; Parameswarappa, S. G.; Witzenrath, M. et al.; Pereira, C. L.; Seeberger, P. H.: Improving vaccines against Streptococcus pneumoniae using synthetic glycans. Proceedings of the National Academy of Sciences of the United States of America 115 (52), S. 13353 - 13358 (2018)

Schumann, B.; Reppe, K.; Kaplonek, P.; Wahlbrink, A.; Chakkumkal, A.; Witzenrath, M.; Pereira, C. L.; Seeberger, P. H.: Development of an efficacious, semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 1. ACS Central Science 4 (3), S. 357 - 361 (2018)

Schumann, B.; Hahm, H. S.; Parameswarappa, S. G.; Reppe, K.; Wahlbrink, A.; Govindan, S.; Kaplonek, P.; Pirofski, L.-a.; Witzenrath, M.; Chakkumkal, A. et al.; Pereira, C. L.; Seeberger, P. H.: A semisynthetic Streptococcus pneumoniae serotype 8 glycoconjugate vaccine. Science Translational Medicine 9 (380), eaaf5347 (2017)

Zhang, Q.; Savagatrup, S.; Kaplonek, P.; Seeberger, P. H.; Swager, T. M.: Janus emulsions for the detection of bacteria. ACS Central Science 3 (4), S. 309 - 313 (2017)

Kaplonek, P.: Improving the immunoprotective effect of carbohydrate vaccine against bacterial pneumonia. Dissertation, Freie Universität, Berlin (2020)